Andersen, M. H., Met, Ö., Svane, I. M., Holmström, M. O., Lisle, T. L., Mortensen, R. E. J., . . . Chen, I. M. (2023). Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationAndersen, Mads Hald, et al. Pre-existing TGF-β-specific T-cell Immunity in Patients with Pancreatic Cancer Predicts Survival After Checkpoint Inhibitors Combined with Radiotherapy. BMJ Publishing Group, 2023.
MLA (9th ed.) CitationAndersen, Mads Hald, et al. Pre-existing TGF-β-specific T-cell Immunity in Patients with Pancreatic Cancer Predicts Survival After Checkpoint Inhibitors Combined with Radiotherapy. BMJ Publishing Group, 2023.
Warning: These citations may not always be 100% accurate.